RxDoctor Payments Data

Mahmoud Al-Saadi, MD

Infectious Disease · Houston, TXNPI 1669905865

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 5th percentile of 576 infectious disease providers in Texas.

See all infectious disease providers in Texas

Medicare billing

Part B allowed, 2024
$584,623
Medicare patients
325
Services billed
22,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala15$58,745
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam55$11,788
Daptomycin23$10,152
Vancomycin Hcl55$8,212
CeftriaxoneCeftriaxone Sodium44$2,011
Rifampin16$1,873
Ethambutol Hcl14$921
Cefadroxil18$521
Doxycycline Hyclate30$367
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$132

Paid to pharmacies, not to this prescriber.

Other infectious disease in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →